Fennec Pharmaceuticals Inc. is a British Columbia corporation with a wholly-owned Delaware subsidiary. Based on the limited excerpt provided from its 10-K filing, the company appears to be a pharmaceutical firm. Specific products, services, and business operations are described in the full Item 1 section, which was not fully included in the provided text.
Q2 FY2026 — expected 2026-08-04
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-27 | 2025-12-31 | 0001104659-26-036182 | EDGAR | 84K words |
| 2025-03-26 | 2024-12-31 | 0001558370-25-003710 | EDGAR | — |
| 2024-03-29 | 2023-12-31 | 0001558370-24-004383 | EDGAR | — |
| 2023-03-29 | 2022-12-31 | 0001558370-23-004948 | EDGAR | — |
| 2022-02-28 | 2021-12-31 | 0001558370-22-002334 | EDGAR | — |
| 2021-03-30 | 2020-12-31 | 0001104659-21-043756 | EDGAR | — |
| 2020-02-14 | 2019-12-31 | 0001104659-20-021132 | EDGAR | — |
| 2019-03-15 | 2018-12-31 | 0001144204-19-014220 | EDGAR | — |
| 2018-03-28 | 2017-12-31 | 0001144204-18-017571 | EDGAR | — |
| 2017-03-29 | 2016-12-31 | 0001144204-17-017299 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001104659-25-111260 | EDGAR | 23K words |
| 2025-08-14 | 2025-06-30 | 0001558370-25-011552 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0001558370-25-007748 | EDGAR | — |
| 2024-11-08 | 2024-09-30 | 0001558370-24-015068 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0001558370-24-012074 | EDGAR | — |
| 2024-05-14 | 2024-03-31 | 0001558370-24-008162 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001558370-23-018614 | EDGAR | — |
| 2023-08-07 | 2023-06-30 | 0001558370-23-013638 | EDGAR | — |
| 2023-05-12 | 2023-03-31 | 0001558370-23-009614 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001558370-22-017857 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0001558370-22-013471 | EDGAR | — |
| 2022-05-12 | 2022-03-31 | 0001558370-22-008461 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-24 | 0001104659-26-033885 | EDGAR | 4K words |
| 2026-03-16 | 0001104659-26-028595 | EDGAR | — |
| 2026-03-04 | 0001104659-26-023484 | EDGAR | — |
| 2026-02-20 | 0001104659-26-018128 | EDGAR | — |
| 2025-12-09 | 0001104659-25-119654 | EDGAR | — |
| 2025-12-02 | 0001104659-25-117697 | EDGAR | — |
| 2025-11-19 | 0001104659-25-113915 | EDGAR | — |
| 2025-11-18 | 0001104659-25-113646 | EDGAR | — |
| 2025-11-17 | 0001104659-25-112912 | EDGAR | — |
| 2025-06-03 | 0001104659-25-055992 | EDGAR | — |
268 total filings indexed. 236 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001211583 |
| Ticker | FENC |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | A1 |
| Website | https://www.fennecpharma.com |
| Listed | 2002-01-28 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report